Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health Network
Clicks: 243
ID: 267073
2017
PWID can be effectively treated for HCV and comply with DAA therapy in an integrated community-based service. However, strategies are required to support client retention until SVR is confirmed.
| Reference Key |
l2017theinitial
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Morris L;Smirnov A;Kvassay A;Leslie E;Kavanagh R;Alexander N;Davey G;Williams O;Gilks C;Najman J;; |
| Journal | The International journal on drug policy |
| Year | 2017 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
female
male
aged
middle aged
young adult
observational study
substance abuse
antiviral agents / therapeutic use*
queensland
intravenous / complications*
community health services / statistics & numerical data
hepatitis c / complications*
hepatitis c / drug therapy*
pmid:28666635
doi:10.1016/j.drugpo.2017.05.056
Leith Morris
Andrew Smirnov
Jake Najman
Opiate Substitution Treatment
Intravenous / drug therapy
Sustained Virologic Response*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.